Invasion and biofilm formation of Burkholderia dolosa is comparable with Burkholderia cenocepacia and Burkholderia multivorans.

[1]  S. McClean,et al.  Comparison of antibiotic susceptibility of Burkholderia cepacia complex organisms when grown planktonically or as biofilm in vitro , 2007, European Journal of Clinical Microbiology & Infectious Diseases.

[2]  L. Kalish,et al.  Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis. , 2006, American journal of respiratory and critical care medicine.

[3]  E. Rietschel,et al.  Prospective evaluation of emerging bacteria in cystic fibrosis. , 2005, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[4]  Joanna B. Goldberg,et al.  The multifarious, multireplicon Burkholderia cepacia complex , 2005, Nature Reviews Microbiology.

[5]  S. Sousa,et al.  Studies on the Involvement of the Exopolysaccharide Produced by Cystic Fibrosis-Associated Isolates of the Burkholderia cepacia Complex in Biofilm Formation and in Persistence of Respiratory Infections , 2004, Journal of Clinical Microbiology.

[6]  H. Ryley.  Burkholderia cepacia complex infection in cystic fibrosis patients: mechanisms of pathogenesis , 2004 .

[7]  P. Vandamme,et al.  Burkholderia cepacia complex genomovars: utilization of carbon sources, susceptibility to antimicrobial agents and growth on selective media , 2003, Journal of applied microbiology.

[8]  J. Lipuma,et al.  Evidence of transmission of Burkholderia cepacia, Burkholderia multivorans and Burkholderia dolosa among persons with cystic fibrosis. , 2003, FEMS microbiology letters.

[9]  R. Gibson,et al.  Pathophysiology and management of pulmonary infections in cystic fibrosis. , 2003, American journal of respiratory and critical care medicine.

[10]  P. Vandamme,et al.  Updated Version of the Burkholderia cepacia Complex Experimental Strain Panel , 2003, Journal of Clinical Microbiology.

[11]  B. Conway,et al.  Biofilm Formation and Acyl Homoserine Lactone Production in the Burkholderia cepacia Complex , 2002, Journal of bacteriology.

[12]  J. Burns,et al.  Correlation between an In Vitro Invasion Assay and a Murine Model of Burkholderia cepacia Lung Infection , 2002, Infection and Immunity.

[13]  J. Lipuma,et al.  Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. , 2001, American journal of respiratory and critical care medicine.

[14]  P. Vandamme,et al.  Diagnostically and Experimentally Useful Panel of Strains from the Burkholderia cepacia Complex , 2000, Journal of Clinical Microbiology.

[15]  C. Mohr,et al.  Invasion and Intracellular Survival ofBurkholderia cepacia , 2000, Infection and Immunity.

[16]  M. Valvano,et al.  Intracellular survival of Burkholderia cepacia complex isolates in the presence of macrophage cell activation. , 1999, Microbiology.

[17]  K. Holroyd,et al.  In Vitro Antibacterial Properties of Pexiganan, an Analog of Magainin , 1999, Antimicrobial Agents and Chemotherapy.

[18]  M. R. Brown,et al.  Increasing resistance of planktonic and biofilm cultures of Burkholderia cepacia to ciprofloxacin and ceftazidime during exponential growth. , 1998, The Journal of antimicrobial chemotherapy.

[19]  Roberto Kolter,et al.  Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis , 1998, Molecular microbiology.

[20]  G. Doern,et al.  Proposed MIC quality control guidelines for National Committee for Clinical Laboratory Standards susceptibility tests using seven veterinary antimicrobial agents: ceftiofur, enrofloxacin, florfenicol, penicillin G-novobiocin, pirlimycin, premafloxacin, and spectinomycin , 1996, Journal of clinical microbiology.

[21]  R. Stern,et al.  Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis , 1990, The Lancet.